Omega-3 Fatty Acids (DHA/EPA) के लिए Mild Cognitive Impairment (MCI)
BResearch suggests 66.7% of RCTs in MCI populations reported positive cognitive outcomes with omega-3 supplementation. DHA appears to be the most critical component for brain-specific cognitive support.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'braincited.com';
const params = 'ingredient\u003Domega\u002D3\u002Ddha\u002Depa\u0026condition\u003Dmild\u002Dcognitive\u002Dimpairment';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
B
निष्कर्ष
Research suggests 66.7% of RCTs in MCI populations reported positive cognitive outcomes with omega-3 supplementation. DHA appears to be the most critical component for brain-specific cognitive support.
Key Study Findings
Systematic Review
n=3582
Natural Products in Alzheimer's Disease: A Systematic Review of Clinical Trials and Underlying Molecular Mechanisms.
Dose: None
बनाम: Placebo or control
Outcome: Cognitive function in AD and MCI patients
प्रभाव: None
None
जनसंख्या: AD and MCI patients aged 50-90 (31 clinical trials)
Randomized Controlled Trial
n=73
12 weeks
Single-blind
Comparing the Efficacy of Combined Intralesional Triamcinolone Acetonide With Topical Calcipotriol Versus Intralesional Triamcinolone Acetonide …
Dose: IL triamcinolone every 4 weeks + calcipotriol twice daily
बनाम: IL triamcinolone acetonide alone
Outcome: Hair density (regrowth scale)
प्रभाव: None
0.018 (scalp subgroup at wk12)
जनसंख्या: Patients with scalp and beard alopecia areata (179 patches)
Review
Effects of Dietary Interventions on Cognitive Outcomes.
Dose: None
बनाम: None
Outcome: Cognitive outcomes (memory, executive function)
प्रभाव: None
None
जनसंख्या: Aging adults with cognitive impairment (review)
Review
Nutrition, cognition and chronic kidney disease: A comprehensive review of interactions and interventions.
Dose: None
बनाम: None
Outcome: None
प्रभाव: None
None
जनसंख्या: None
Other
Milk Fat Globules: 2024 Updates.
Dose: None
बनाम: None
Outcome: Inflammatory markers
प्रभाव: None
None
जनसंख्या: None
Systematic Review
The Role of Omega-3 Fatty Acid Supplementation in Slowing Cognitive Decline Among Elderly Patients With …
Dose: None
बनाम: None
Outcome: Cognitive function
प्रभाव: None
None
जनसंख्या: Alzheimer's disease patients
Key Statistics
18
अध्ययन
3200
प्रतिभागी
↑
Positive
B
ग्रेड
Referenced Papers
European journal of …
2025
8 उद्धरण
Nutrients
2025
6 उद्धरण
Natural Products in Alzheimer's Disease: A Systematic Review of Clinical Trials and Underlying Molecular Mechanisms.
Systematic Review
International journal of …
2025
2 उद्धरण
Journal of cutaneous …
2025
European journal of …
2024
16 उद्धरण
Lasers in medical …
2024
10 उद्धरण
Healthcare (Basel, Switzerland)
2024
9 उद्धरण
Newborn (Clarksville, Md.)
2024
9 उद्धरण
Cureus
2024
8 उद्धरण
Journal of cosmetic …
2024
1 उद्धरण
American family physician
2024
Current opinion in …
2023
58 उद्धरण
Nutrition reviews
2023
18 उद्धरण
Archives of dermatological …
2023
3 उद्धरण
Vitamin Supplementation and Dementia: A Systematic Review.
Systematic Review
Nutrients
2022
76 उद्धरण
Brain, behavior, and …
2022
64 उद्धरण
European journal of …
2022
63 उद्धरण
The American journal …
2022
18 उद्धरण
Journal of Ayub …
2022
4 उद्धरण
The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review.
Review
Journal of clinical …
2021
38 उद्धरण
Antioxidants (Basel, Switzerland)
2021
33 उद्धरण
Diet enriched in omega-3 fatty acids alleviates olfactory system deficits in APOE4 transgenic mice.
Other
The European journal …
2021
4 उद्धरण
The Senior care …
2021
2 उद्धरण
Nutrients
2020
72 उद्धरण
Journal of cutaneous …
2020
21 उद्धरण
Psychiatrike = Psychiatriki
2020
15 उद्धरण
Journal of Alzheimer's …
2020
14 उद्धरण
FASEB journal : …
2020
8 उद्धरण
Omega-3 fatty acids and cognitive decline: a systematic review.
Systematic Review
Nutricion hospitalaria
2019
40 उद्धरण
Alzheimer's research & …
2019
29 उद्धरण
The journal of …
2018
24 उद्धरण
Journal of Alzheimer's …
2018
12 उद्धरण
FASEB journal : …
2017
41 उद्धरण
Actas espanolas de …
2017
22 उद्धरण
FASEB journal : …
2017
21 उद्धरण
Current Alzheimer research
2017
7 उद्धरण
Journal of Alzheimer's …
2016
128 उद्धरण
NeuroImage
2016
118 उद्धरण
FP essentials
2016
11 उद्धरण
Individually modifiable risk factors to ameliorate cognitive aging: a systematic review and meta-analysis.
Meta-Analysis
Climacteric : the …
2015
92 उद्धरण
Journal of Alzheimer's …
2015
8 उद्धरण
European journal of …
2014
204 उद्धरण
Nutrition (Burbank, Los …
2014
74 उद्धरण
Acta clinica Belgica
2014
44 उद्धरण
Nutricion hospitalaria
2014
17 उद्धरण
Advances in nutrition …
2013
155 उद्धरण
Journal of Alzheimer's …
2012
257 उद्धरण
Journal of Alzheimer's …
2012
137 उद्धरण
Alzheimer disease and …
2011
52 उद्धरण
Molecular neurobiology
2010
145 उद्धरण
Journal of Alzheimer's …
2010
110 उद्धरण
Journal of Alzheimer's …
2010
55 उद्धरण
Women's health (London, …
2010
48 उद्धरण
JAMA
2009
304 उद्धरण
Progress in neuro-psychopharmacology …
2008
388 उद्धरण
Alternative medicine review …
2008
Alternative medicine review …
2007
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
सामान्य रूप से उपयोग की जाने वाली खुराकें
- general:
- 1,000-2,000 mg combined DHA/EPA per day
- cognitivesupport:
- 1,000-1,700 mg/day (optimal dose-response curve)
अधिकतम सीमा: 3,000 mg/day combined DHA/EPA (FDA GRAS)
अनुसंधान में अध्ययन की गई खुराकें
| खुराक | अवधि | प्रभाव | N |
|---|---|---|---|
| None | -- | Mixed | 3582 |
| IL triamcinolone every 4 weeks + calcipotriol twice daily | 12 weeks | Positive | 73 |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| Vitamin D3 vs triamcinolone acetonide | 12 weeks | Positive | 40 |
| None | -- | Positive | -- |
सेवन का सर्वोत्तम समय: With meals containing fat for better absorption
Safety & Side Effects
रिपोर्ट किए गए दुष्प्रभाव
- ⚠ Fishy aftertaste or burping
- ⚠ Mild gastrointestinal discomfort
- ⚠ Potential increased bleeding time at very high doses
- ⚠ May lower blood pressure slightly
ज्ञात अंतःक्रियाएँ
- ● Anticoagulants and antiplatelet drugs (may increase bleeding risk at high doses)
- ● Blood pressure medications (additive hypotensive effect)
- ● Orlistat (may reduce omega-3 absorption)
सहनीय अधिकतम सेवन: 3,000 mg/day combined DHA/EPA (FDA GRAS)
कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।
Frequently Asked Questions
Does Omega-3 Fatty Acids (DHA/EPA) help with Mild Cognitive Impairment (MCI)?
Based on 18 studies with 3,200 participants, there is moderate evidence from clinical studies that Omega-3 Fatty Acids (DHA/EPA) may support Mild Cognitive Impairment (MCI) management. Our evidence grade is B (Good Evidence).
How much Omega-3 Fatty Acids (DHA/EPA) should I take for Mild Cognitive Impairment (MCI)?
Studies have used various dosages. A commonly studied range is 1,000-2,000 mg combined DHA/EPA per day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (DHA/EPA)?
Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal discomfort, Potential increased bleeding time at very high doses, May lower blood pressure slightly. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (DHA/EPA) and Mild Cognitive Impairment (MCI)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 18 peer-reviewed studies with 3,200 total participants. The overall direction of effect is positive.
Related Evidence
इसके लिए अन्य सामग्री Mild Cognitive Impairment (MCI)
Omega-3 Fatty Acids (DHA/EPA) अन्य स्वास्थ्य स्थितियों के लिए
FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।